Stay up to date with the latest Mycovia news, press releases, and more. If you have any questions or comments regarding media inquiries, please reach out to mediarelations@mycovia.com.

10.21.2019

Mycovia Pharmaceuticals to Present at 2019 BIO Investor Forum

Download PDF

10.16.2019

Mycovia Pharmaceuticals Announces Partnership with Gedeon Richter to Commercialize and Manufacture VT-1161 for Recurrent Vulvovaginal Candidiasis

Download PDF

07.31.2019

Mycovia Appoints Tiffany Ahlers as Senior Vice President, Commercialization

Download PDF

06.17.2019

Mycovia Pharmaceuticals and Jiangsu Hengrui Medicine Announce Partnership to Develop and Commercialize VT-1161 for Recurrent Vulvovaginal Candidiasis and Other Fungal Conditions

Download PDF

04.11.2019

Study Published in Antimicrobial Agents and Chemotherapy Finds Antifungal Compound VT-1598 Developed by Mycovia Pharmaceuticals Demonstrates In Vitro and In Vivo Activity Against Deadly Candida Auris Fungus

Download PDF
Transforming healthcare together Careers at Mycovia
Working together to transform healthcare Contact Us